A novel system to map protein interactions reveals evolutionarily conserved immune evasion pathways on transmissible cancers
Authors:
Preprint
- 7 November 2019
- preprint
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 831404
Abstract
Immune checkpoint immunotherapy has revolutionized medicine, but translational success for new treatments remains low. Around 40% of humans and Tasmanian devils (Sarcophilus harrisii) develop cancer in their lifetime, compared to less than 10% for most species. Additionally, devils are affected by two of the three known transmissible cancers in mammals. Unfortunately, little is known about of immune checkpoints in devils and other non-model species, largely due to a lack of species-specific reagents. We developed a simple cut-and-paste reagent development method applicable to any vertebrate species and show that immune checkpoint interactions are conserved across 160 million years of evolution. The inhibitory checkpoint molecule CD200 is highly expressed on devil facial tumor cells. We are the first to demonstrate that co-expression of CD200R1 can block CD200 expression. The evolutionarily conserved pathways suggest that naturally occurring cancers in devils and other species can serve as models for understanding cancer and immunological tolerance.GRAPHICALKeywords
All Related Versions
- Published version: Science Advances, 6 (27), eaba5031.
This publication has 74 references indexed in Scilit:
- Structures of CD200/CD200 Receptor Family and Implications for Topology, Regulation, and EvolutionStructure, 2013
- Reversible epigenetic down-regulation of MHC molecules by devil facial tumour disease illustrates immune escape by a contagious cancerProceedings of the National Academy of Sciences, 2013
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in CancerNew England Journal of Medicine, 2012
- Full-length transcriptome assembly from RNA-Seq data without a reference genomeNature Biotechnology, 2011
- B7-H2 Is a Costimulatory Ligand for CD28 in HumanImmunity, 2011
- CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemiaLeukemia, 2011
- The Counterbalance Theory for Evolution and Function of Paired ReceptorsImmunity, 2008
- Protein production and purificationNature Methods, 2008
- Clonal Origin and Evolution of a Transmissible CancerCell, 2006
- Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent proteinNature Biotechnology, 2004